IP Library Granted Patent US 9,295,841
Granted Patent B2
US 9,295,841 · App. 14/656,256 · Granted Mar 29, 2016

High-frequency electrical nerve block

Inventors: Zi-Ping Fang (Beachwood, OH); Jon J. Snyder (Kirtland, OH); Nemath Syed Shah (Lyndhurst, OH)
Assignee: Meuros Medical, Inc.
A61N1/36071A61N1/0551A61N1/0556A61N1/36153A61N1/36157A61N1/36171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,295,841
App. No.
14/656,256
Granted
Mar 29, 2016
Kind
B2
Abstract

A method and apparatus that resulted in blocking an action potential in a nerve.

Claims (15)

1. A method of relieving post-amputation pain in an amputee patient, the method comprising providing a device for administering a frequency between 5 kHz to 50 kHz to a nerve at a site proximal to a neuroma by a plurality of contact surfaces with the nerve to block conduction of an action potential in the nerve and not stimulate and not generate an action potential in the nerve, at a voltage between 4 V peak-to-peak (Vpp) to 20 Vpp or at a current between 4 mA peak-to-peak (mApp) to 26 mApp for an interval sufficient to relieve pain.

2. The method of claim 1 achieving at least equal analgesic effect in the patient in the absence of a pharmaceutical analgesic.

3. The method of claim 2 achieving at least one of enhanced analgesia efficacy or enhanced analgesia predictability compared to lidocaine block analgesia.

4. The method of claim 3 further comprising optionally repeating application of the waveform at an interval greater than lidocaine half-life.

5. The method of claim 4 where the neuropathic pain is selected from the group consisting of post-surgical pain, pain from shingles, neuropathic diabetic pain, migraine pain, and combinations thereof.

6. The method of claim 1 achieving at least equal analgesic effect in the patient relative to either spinal cord stimulation (SCS) and/or peripheral nerve stimulation (PNS).

7. The method of claim 1 further comprising optionally repeating application of the waveform at an interval not shorter than nine hours.

8. The method of claim 1 where the waveform generator is battery-powered and the interval decreases an interval for battery recharging.

9. The method of claim 1 where the waveform is applied by operatively connecting the nerve waveform generator to an implanted electrode.

10. The method of claim 1 where the waveform generator is implanted in the patient and is activated by a remote controller.

11. The method of claim 1 where the waveform generator is external to the patient and is activated at the waveform generator.

12. A method of relieving neuropathic pain in a patient in need thereof, the method comprising providing a device for administering a frequency between 5 kHz to 50 kHz to a nerve at a site proximal to a site of pain by a plurality of contact surfaces with the nerve to block conduction of an action potential in the nerve and not stimulate and not generate an action potential in the nerve, at a voltage between 4 V peak-to-peak (Vpp) to 20 Vpp or at a current between 4 mA peak-to-peak (mApp) to 26 mApp for an interval sufficient to relieve pain.

13. A method of providing improved mobility in an amputee above or below a knee, the method comprising providing a device for administering a frequency between 5 kHz to 50 kHz to a nerve at a site proximal to a neuroma by a plurality of contact surfaces with the nerve to block conduction of an action potential in the nerve and not stimulate and not generate an action potential in the nerve, at a voltage between 4 V peak-to-peak (Vpp) to 20 Vpp or at a current between 4 mA peak-to-peak (mApp) to 26 mApp for an interval sufficient to relieve pain facilitating tolerance of a lower limb prosthetic resulting in improved mobility.

14. The method of claim 13 where the nerve is selected from the group consisting of a tibial nerve or a sciatic nerve.

15. The method of claim 13 where the nerve diameter is up to 12 mm.

Assignments (4)
SECURITY INTEREST Recorded Dec 19, 2025
From: NEUROS MEDICAL, INC.
To: TRINITY CAPITAL INC., AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 073280/0256 →
RELEASE OF SECURITY INTEREST Recorded Dec 19, 2025
From: TRINITY CAPITAL INC.
To: NEUROS MEDICAL, INC.
Reel/Frame 073280/0362 →
SECURITY INTEREST Recorded Aug 22, 2023
From: NEUROS MEDICAL, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 064667/0276 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2015
From: FANG, ZI-PING; SNYDER, JON J.; SHAH, NEMATH SYED
To: NEUROS MEDICAL, INC.
Reel/Frame 035201/0946 →
Continuity (4)
Continuation In Part 14276200 · May 13, 2014
Continuation 13474926 · May 18, 2012
Provisional Application 61487877 · May 19, 2011
Related Publication 20150182749A1 · Jul 2, 2015